![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
The 10th International Congress of Neuroimmunology, including the 10th European School of Neuroimmunology Course, was held by the International Society of Neuroimmunology in Sitges (Barcelona, Spain) on 26–30 October 2010. The conference covered a wide spectrum of issues and challenges in both basic science and clinical aspects of neuroimmunology. Data and ideas were shared through a variety of programs, including review talks and poster sessions. One of the topics of the congress was whether multiple sclerosis is a homogenous or heterogenous disease, clinically and pathologically, throughout its course.
Financial & competing interests disclosure
The conference was held in cooperation with the ISNI and ESNI. The conference was supported by the ISNI, Associazione Italiana Di Neuroimmunologia, ECTRIMS, Merck and Teva, and sponsored by Novartis, Teva, Biogen Idec, Bayer, Merck, Alicia Koplowitz, Biomarin, Grifols, Miltenyi Biotec, Grupo Uriach Pharma, GAEM and red Española de esclerosis múltiple. This work was supported by exploratory/development grant R21NS059724 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) and by COBRE Center grant 5P20-RR018724 from the National Center for Research Resources of the NIH. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.